Image (546b07bd 7dba 49c9 8caf 7914600d4d19 01)
Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 70518-4553
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-4553). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (546b07bd 7dba 49c9 8caf 7914600d4d19 02)
This is a comparison of the reduction in CPS (Complex Partial Seizure) rate between Divalproex Sodium Delayed-Release Tablets and Placebo. The graph shows the percentage of patients with improvement, no change, or worsening of CPS.*
Image (546b07bd 7dba 49c9 8caf 7914600d4d19 03)
This text appears to describe a chart or graph showing the reduction in CPS (presumably clinical pharmacy services) rate based on different percentages. The table may present percentages ranging from 100% to 2%, including categories like "No change", "High Dose Divalproex Sodium Delayed-Release Tablets" and "Low Dose Divalproex Sodium Delayed-Release Tablets". It also mentions the percentage of patients involved in this reduction analysis.*
Image (546b07bd 7dba 49c9 8caf 7914600d4d19 04)
This is a list of numerical values followed by notes on a medication called Divalproex sodium extended-release tablets. The text includes information about the dosage, a reference to placebo, and a measurement denoted by "p=0.006".*
Remedy_label (Remedy Label)
This text provides information about Divalproex Sodium tablets manufactured by Unichem Labs Ltd. in Goa, India. The tablets are extended-release and come in a pack of 30 tablets with a dosage of 500 mg. The usual dosage instructions are included in the insert. The medication should be stored at a temperature of 20-25°C (68-77°F) with excursions allowed to 15-30°C (59-86°F). The lot number and expiration date are missing from the text. The tablets were repackaged by RemedyRepack, a company located in Indiana, PA, with a contact number provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
